BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2220364)

  • 1. Intraocular levels of cefuroxime in uninflamed rabbit eyes.
    Koul S; Philipson A; Philipson BT; Kock E; Nylén P
    Acta Ophthalmol (Copenh); 1990 Aug; 68(4):455-65. PubMed ID: 2220364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraocular levels of cefuroxime in inflamed rabbit eyes.
    Koul S; Philipson A; Philipson BT; Arvidson S
    Eur J Ophthalmol; 1993; 3(2):61-5. PubMed ID: 8353431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma.
    Buitrago E; Del Sole MJ; Torbidoni A; Fandino A; Asprea M; Croxatto JO; Chantada GL; Bramuglia GF; Schaiquevich P
    Exp Eye Res; 2013 Mar; 108():103-9. PubMed ID: 23333535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal flomoxef sodium in rabbits.
    Mochizuki K; Torisaki M; Yamashita Y; Komatsu M; Tanahashi T
    Ophthalmic Res; 1993; 25(2):128-36. PubMed ID: 8321517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The intraocular penetration and retinal toxicity of teicoplanin.
    Carney M; Kao G; Peyman GA; Fiscella R; Staneck J
    Ophthalmic Surg; 1988 Feb; 19(2):119-23. PubMed ID: 2964586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicity and clearance of intravitreal cefotetan.
    Philipp W; Schmid K; Steiner HJ; Pümpel B; Allerberger F; Aichberger HP; Mayer W
    Graefes Arch Clin Exp Ophthalmol; 1990; 228(5):475-80. PubMed ID: 2227495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiological and toxicological effects of cefuroxime on the albino rabbit retina.
    Shahar J; Zemel E; Perlman I; Loewenstein A
    Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):906-14. PubMed ID: 22159021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uptake and pharmacokinetics of cefuroxime in rabbits after intravitreal, intracameral, and topical dosing: relevance to human ocular injection of cefuroxime.
    Jairam RK; Mallurwar SR; Gabani BB; Zakkula A; Kiran V; Dittakavi S; Sulochana SP; Mohd Z; Srinivas NR; Mullangi R
    Xenobiotica; 2020 Mar; 50(3):339-345. PubMed ID: 31144563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of vitreous clearance and potential retinal toxicity of intravitreal lornoxicam (xefo).
    Diakonis VF; Tsourdou A; Tzatzarakis MN; Tsika C; Charisis S; Naoumidi I; Plainis S; Tsilimbaris MK
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):627-32. PubMed ID: 23556534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional ocular gentamicin levels after transcorneal and transscleral iontophoresis.
    Grossman RE; Chu DF; Lee DA
    Invest Ophthalmol Vis Sci; 1990 May; 31(5):909-16. PubMed ID: 2335452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinal safety of oral and topical ofloxacin in rabbits.
    Cohen RG; Raizman M; Callina C; Lahav M
    J Ocul Pharmacol Ther; 1997 Aug; 13(4):369-79. PubMed ID: 9261772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular tissue distribution and pharmacokinetic study of a small 13kDa domain antibody after intravitreal, subconjuctival and eye drop administration in rabbits.
    Gough G; Szapacs M; Shah T; Clements P; Struble C; Wilson R
    Exp Eye Res; 2018 Feb; 167():14-17. PubMed ID: 29074387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of bevacizumab after topical, subconjunctival, and intravitreal administration in rabbits.
    Nomoto H; Shiraga F; Kuno N; Kimura E; Fujii S; Shinomiya K; Nugent AK; Hirooka K; Baba T
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4807-13. PubMed ID: 19324856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraocular penetration and effect on the retina of fluconazole.
    Mochizuki K; Yamashita Y; Torisaki T; Komatsu K; Tanahashi T; Sakai H
    Lens Eye Toxic Res; 1992; 9(3-4):537-46. PubMed ID: 1301802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraocular 9-([2-hydroxy-1-(hydroxymethyl) ethoxy] methyl) guanine levels after intravitreal and subconjunctival administration.
    Schulman J; Peyman GA; Horton MB; Liu J; Fiscella R; Pulido J; Barber JC; de Miranda P
    Ophthalmic Surg; 1986 Jul; 17(7):429-32. PubMed ID: 3014412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transscleral Coulomb-controlled iontophoresis of methylprednisolone into the rabbit eye: influence of duration of treatment, current intensity and drug concentration on ocular tissue and fluid levels.
    Behar-Cohen FF; El Aouni A; Gautier S; David G; Davis J; Chapon P; Parel JM
    Exp Eye Res; 2002 Jan; 74(1):51-9. PubMed ID: 11878818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative intraocular penetration of topical and injected cefuroxime.
    Jenkins CD; Tuft SJ; Sheraidah G; McHugh DA; Buckley RJ
    Br J Ophthalmol; 1996 Aug; 80(8):685-8. PubMed ID: 8949709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moxalactam (Moxam) in the treatment of experimental staphylococcal endophthalmitis.
    Leeds NH; Peyman GA; House B
    Ophthalmic Surg; 1982 Aug; 13(8):653-6. PubMed ID: 6215601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intravitreal injection of norfloxacin on the retina in pigmented rabbits.
    Tanahashi T; Mochizuki K; Torisaki M; Yamashita Y; Komatsu M; Higashide T; Ogata M
    Lens Eye Toxic Res; 1992; 9(3-4):493-503. PubMed ID: 1301799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study on ocular safety of intravitreal infliximab in a rabbit model.
    Giansanti F; Ramazzotti M; Vannozzi L; Rapizzi E; Fiore T; Iaccheri B; Degl' Innocenti D; Moncini D; Menchini U
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1151-6. PubMed ID: 18326743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.